Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
VeriSign
VRSN
$26.3B
| $99.6M | 0.05% |
486,128
-21,824
| -4% | -$4.51M |
|
327
NewMarket
NEU
$7.24B
| $99.4M | 0.05% |
290,248
+32,975
| +13% | +$12.5M |
|
|
ALTR
328
DELISTED
Altair Engineering Inc
ALTR
| $99.1M | 0.05% |
2,360,453
-186,615
| -7% | -$7.51M |
|
329
Labcorp
LH
$25.2B
| $99.1M | 0.05% |
612,490
-60,772
| -9% | -$9.63M |
|
|
SAGE
330
DELISTED
Sage Therapeutics
SAGE
| $99M | 0.05% |
1,619,701
+160,025
| +11% | +$8.11M |
|
331
NeoGenomics
NEO
$1.96B
| $98.9M | 0.05% |
2,680,031
-60,939
| -2% | -$2.27M |
|
332
Wendy's
WEN
$1.46B
| $98.7M | 0.05% |
4,427,451
+593,446
| +15% | +$13.1M |
|
|
MYOK
333
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $98.7M | 0.05% |
723,989
-459,647
| -39% | -$48.9M |
|
334
Goldman Sachs
GS
$289B
| $98.1M | 0.05% |
487,952
+22,663
| +5% | +$4.61M |
|
335
Donaldson
DCI
$10.7B
| $97.4M | 0.05% |
2,098,083
-135,145
| -6% | -$6.57M |
|
336
STAG Industrial
STAG
$7.5B
| $97.4M | 0.05% |
3,193,893
-564,938
| -15% | -$17.8M |
|
|
EQC
337
DELISTED
Equity Commonwealth
EQC
| $97.3M | 0.05% |
3,653,622
-562,761
| -13% | -$17.4M |
|
338
Brady Corp
BRC
$4.46B
| $97.3M | 0.05% |
2,430,835
+114,416
| +5% | +$5.24M |
|
|
SUM
339
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $96.5M | 0.05% |
5,930,525
-112,317
| -2% | -$1.8M |
|
340
3M
MMM
$91.8B
| $96.4M | 0.05% |
720,170
+118,535
| +20% | +$15.9M |
|
341
Zebra Technologies
ZBRA
$13.5B
| $95.8M | 0.05% |
379,467
+103,342
| +37% | +$27.8M |
|
342
NXP Semiconductors
NXPI
$60.8B
| $95.1M | 0.05% |
762,731
-264,597
| -26% | -$32.3M |
|
343
Rhythm Pharmaceuticals
RYTM
$7.31B
| $95.1M | 0.05% |
4,386,370
-24,118
| -0.5% | -$553K |
|
344
Roper Technologies
ROP
$40.4B
| $95M | 0.05% |
240,279
+41,817
| +21% | +$17.4M |
|
345
PTC Therapeutics
PTCT
$6.18B
| $94.4M | 0.05% |
2,018,563
+201,752
| +11% | +$9.93M |
|
346
Waste Management
WM
$95B
| $94.3M | 0.05% |
833,513
-1,029,252
| -55% | -$114M |
|
347
Eaton
ETN
$141B
| $94.2M | 0.05% |
923,364
+410,128
| +80% | +$40.1M |
|
348
Hanover Insurance
THG
$8.13B
| $93.7M | 0.05% |
1,005,216
-2,872
| -0.3% | -$285K |
|
349
Vanguard S&P 500 ETF
VOO
$956B
| $93M | 0.05% |
302,273
+1,298
| +0.4% | +$395K |
|
350
Southwest Gas
SWX
$6.64B
| $92.7M | 0.05% |
1,468,416
+54,459
| +4% | +$3.64M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.